These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34391579)

  • 1. Reaching racial/ethnic and sexual and gender minorities with HIV prevention information via social marketing.
    Marshall B; Salabarría-Peña Y; Johnson W; Moore L
    Eval Program Plann; 2022 Feb; 90():101982. PubMed ID: 34391579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding PrEP Services for Men Who Have Sex With Men and Transgender Persons Through Health Department Programs: Key Processes and Outcomes From Project PrIDE, 2015-2019.
    Mulatu MS; Carter JW; Flores SA; Benton S; Galindo CA; Johnson WD; Wilkes AL; Prather C
    Public Health Rep; 2023; 138(1):31-42. PubMed ID: 35023401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using evaluation to enhance a pre-exposure prophylaxis (PrEP) social marketing campaign in real time in Los Angeles County, California.
    Nakelsky S; Moore L; Garland WH
    Eval Program Plann; 2022 Feb; 90():101988. PubMed ID: 34452743
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Keene LC; Dehlin JM; Pickett J; Berringer KR; Little I; Tsang A; Bouris AM; Schneider JA
    Cult Health Sex; 2021 Mar; 23(3):397-413. PubMed ID: 32212962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating for health equity among a cluster of health departments implementing PrEP services.
    Carter JW; Salabarría-Peña Y; Fields EL; Robinson WT
    Eval Program Plann; 2022 Feb; 90():101981. PubMed ID: 34392968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communicative appeals and messaging frames in visual media for HIV pre-exposure prophylaxis promotion to cisgender and transgender women.
    Rosen JG; Toomre T; To C; Olatunde PF; Cooper L; Glick JL; Park JN
    Cult Health Sex; 2023 Aug; 25(8):1007-1023. PubMed ID: 36074902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrEP navigation continuum among men who have sex with men, trans women, and people with alternative gender identities in three California counties.
    Parrish KC; Johnson HZ; Williams SL
    Eval Program Plann; 2022 Feb; 90():101998. PubMed ID: 34544606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation and Reach of a Pre-Exposure Prophylaxis Social Marketing Campaign for Latino, Latina, and Latinx Populations: Development Study.
    Shah HS; Serrano PA; Phillips Ii G
    JMIR Form Res; 2024 Jul; 8():e52842. PubMed ID: 39018099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-exposure prophylaxis makes it possible to better live one's sexuality and guide men who have sex with men towards a responsible approach to their health: a phenomenological qualitative study about primary motivations for PrEP.
    Bistoquet M; Makinson A; Tribout V; Perrollaz C; Bourrel G; Reynes J; Oude Engberink A
    AIDS Res Ther; 2021 Jan; 18(1):2. PubMed ID: 33413434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe "Risk" Messaging and Normalize Preventative Health.
    Jaiswal J; LoSchiavo C; Meanley S; Hascher K; Cox AB; Dunlap KB; Singer SN; Halkitis PN
    AIDS Behav; 2021 Oct; 25(10):3057-3073. PubMed ID: 33830327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'There are people like me who will see that, and it will just wash over them': Black sexual minority men's perspectives on messaging in PrEP visual advertisements.
    Kalwicz DA; Rao S; Modrakovic DX; Zea MC; Dovidio JF; Magnus M; Kharfen M; Patel VV; Calabrese SK
    Cult Health Sex; 2023 Oct; 25(10):1371-1386. PubMed ID: 36598172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
    Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
    PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sources of Information about Pre-Exposure Prophylaxis (PrEP) and Associations with PrEP Stigma, Intentions, Provider Discussions, and Use in the United States.
    Walsh JL; Zarwell M; John SA; Quinn KG
    J Sex Res; 2023; 60(5):728-740. PubMed ID: 36036718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of Awareness of and Willingness to Use Pre-exposure Prophylaxis (PrEP) in Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Geosocial-Networking Smartphone Applications in New York City.
    Goedel WC; Halkitis PN; Greene RE; Duncan DT
    AIDS Behav; 2016 Jul; 20(7):1435-42. PubMed ID: 26966013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding willingness to use oral pre-exposure prophylaxis for HIV prevention among men who have sex with men in China.
    Wang X; Bourne A; Liu P; Sun J; Cai T; Mburu G; Cassolato M; Wang B; Zhou W
    PLoS One; 2018; 13(6):e0199525. PubMed ID: 29928008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Microsimulation Modeling to Inform EHE Implementation Strategies in Los Angeles County.
    Drabo EF; Moucheraud C; Nguyen A; Garland WH; Holloway IW; Leibowitz A; Suen SC
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S167-S176. PubMed ID: 35703769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness of, interest in, and willingness to pay for HIV pre-exposure prophylaxis among Canadian gay, bisexual, and other men who have sex with men.
    Morgan J; Ferlatte O; Salway T; Wilton J; Hull M
    Can J Public Health; 2018 Dec; 109(5-6):791-799. PubMed ID: 29981103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
    Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
    PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness, preferred ways and potential barriers to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in China.
    Yu S; Cross W; Lam LLY; Zhang K; Banik B; Li X; Wang H
    BMJ Open; 2021 Oct; 11(10):e053634. PubMed ID: 34716167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.